95 related articles for article (PubMed ID: 2580626)
21. Response of different mammary epithelial cell lines to a mammary derived growth inhibitor (MDGI).
Lehmann W; Widmaier R; Langen P
Biomed Biochim Acta; 1989; 48(1):143-51. PubMed ID: 2775246
[TBL] [Abstract][Full Text] [Related]
22. Anchorage-independent growth-conferring factor production by rat mammary tumor cells.
Zwiebel JA; Davis MR; Kohn E; Salomon DS; Kidwell WR
Cancer Res; 1982 Dec; 42(12):5117-25. PubMed ID: 6291748
[TBL] [Abstract][Full Text] [Related]
23. Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alpha.
Ethier SP; Langton BC; Dilts CA
Mol Carcinog; 1996 Feb; 15(2):134-43. PubMed ID: 8599580
[TBL] [Abstract][Full Text] [Related]
24. Sarcoma growth factor and other transforming peptides produced by human cells: interactions with membrane receptors.
Todaro GJ; De Larco JE; Fryling CM
Fed Proc; 1982 Nov; 41(13):2996-3003. PubMed ID: 6292003
[TBL] [Abstract][Full Text] [Related]
25. Identification and partial purification of a low-molecular-weight growth inhibitor formed by density-inhibited, tumorigenic V79 Chinese hamster cells.
Koga T; Nakano S; Nakayama M; Kounoue E; Nagafuchi S; Niho Y; Yamada H
Cancer Res; 1986 Sep; 46(9):4431-7. PubMed ID: 3731099
[TBL] [Abstract][Full Text] [Related]
26. Preparation of a monoclonal antibody to a melanoma growth-stimulatory activity released into serum-free culture medium by Hs0294 malignant melanoma cells.
Lawson DH; Thomas HG; Roy RG; Gordon DS; Chawla RK; Nixon DW; Richmond A
J Cell Biochem; 1987 Jul; 34(3):169-85. PubMed ID: 3611199
[TBL] [Abstract][Full Text] [Related]
27. Transforming growth factor beta: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells.
Arteaga CL; Tandon AK; Von Hoff DD; Osborne CK
Cancer Res; 1988 Jul; 48(14):3898-904. PubMed ID: 3164252
[TBL] [Abstract][Full Text] [Related]
28. Transforming growth factors produced by normal and neoplastically transformed rat liver epithelial cells in culture.
Liu C; Tsao MS; Grisham JW
Cancer Res; 1988 Feb; 48(4):850-5. PubMed ID: 3276400
[TBL] [Abstract][Full Text] [Related]
29. [A transforming growth factor-beta like growth factor in mouse embryonal carcinoma cells].
Shi WK; Yao Z
Shi Yan Sheng Wu Xue Bao; 1989 Jun; 22(2):213-23. PubMed ID: 2800839
[TBL] [Abstract][Full Text] [Related]
30. Urinary transforming growth factors in neoplasia: separation of 125I-labeled transforming growth factor-alpha from epidermal growth factor in human urine.
Stromberg K; Hudgins WR
Cancer Res; 1986 Nov; 46(11):6004-10. PubMed ID: 3019543
[TBL] [Abstract][Full Text] [Related]
31. Identification of a 15,000-molecular-weight form of immunoreactive transforming growth factor alpha in extracts of porcine pituitary.
Riss TL; Sirbasku DA
J Cell Physiol; 1989 Feb; 138(2):393-404. PubMed ID: 2918041
[TBL] [Abstract][Full Text] [Related]
32. Normal B cell precursors responsive to recombinant murine IL-7 and inhibition of IL-7 activity by transforming growth factor-beta.
Lee G; Namen AE; Gillis S; Ellingsworth LR; Kincade PW
J Immunol; 1989 Jun; 142(11):3875-83. PubMed ID: 2785567
[TBL] [Abstract][Full Text] [Related]
33. A T-helper cell x Molt4 human hybridoma constitutively producing B-cell stimulatory and inhibitory factors.
Rosén A; Uggla C; Szigeti R; Kallin B; Lindqvist C; Zeuthen J
Lymphokine Res; 1986; 5(3):185-204. PubMed ID: 2943947
[TBL] [Abstract][Full Text] [Related]
34. Response of primary human lung carcinomas to autocrine growth factors produced by a lung carcinoma cell line.
Siegfried JM; Owens SE
Cancer Res; 1988 Sep; 48(17):4976-81. PubMed ID: 3165706
[TBL] [Abstract][Full Text] [Related]
35. Small molecular mass inhibitor of growth of MDCK cells derived from pig spinal cord.
Emoto Y; Kawahara E; Koga Y; Ito T; Tawada K
J Cell Physiol; 2001 Mar; 186(3):350-6. PubMed ID: 11169973
[TBL] [Abstract][Full Text] [Related]
36. Growth inhibition of human tumor cells in soft-agar cultures by treatment with low levels of adenosine 5'-triphosphate.
Rapaport E; Fishman RF; Gercel C
Cancer Res; 1983 Sep; 43(9):4402-6. PubMed ID: 6871873
[TBL] [Abstract][Full Text] [Related]
37. Transforming growth factors type beta 1 and beta 2 are equipotent growth inhibitors of human breast cancer cell lines.
Zugmaier G; Ennis BW; Deschauer B; Katz D; Knabbe C; Wilding G; Daly P; Lippman ME; Dickson RB
J Cell Physiol; 1989 Nov; 141(2):353-61. PubMed ID: 2808542
[TBL] [Abstract][Full Text] [Related]
38. Purification of a low molecular weight factor that induces differentiation and inhibits growth in myeloid leukemia cells.
Nakaya K; Kumakawa N; Iinuma H; Nakamura Y
Cancer Res; 1988 Aug; 48(15):4201-5. PubMed ID: 3164645
[TBL] [Abstract][Full Text] [Related]
39. Multiplicity of transforming growth factors in human malignant effusions.
Seo MK; Lynch KE; Podolsky DK
Cancer Res; 1988 Apr; 48(7):1792-7. PubMed ID: 2894891
[TBL] [Abstract][Full Text] [Related]
40. Characterization of a low-molecular-weight growth inhibitor formed by density-inhibited, tumorigenic V79 Chinese hamster cells.
Koga T; Nakano S; Ichinose I; Yamada H; Niho Y
Cancer Res; 1988 Jul; 48(13):3737-41. PubMed ID: 3378215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
